Wolters Kluwer puts Adis on block

Share this article:

Wolters Kluwer said it will divest its Pharma Solutions business unit, in two parts.

Brands now on the block include the PHAST syndicated prescription data service, plus the Adis R&D Insight and inThought pipeline analysis tools. 

Pharma Solutions “no longer fits with the [company] growth strategy,” which is to focus spending and investment in core healthcare provider markets, Robert Dekker, VP of communications for Wolters Kluwer Health & Pharma Solutions, told MM&M.

Health brands that are staying include the Lippincott Williams & Wilkins textbooks and journals, and UpToDate web and mobile medical apps.

Officials expect to close a sale around, or shortly after, year's end. William Blair & Co. and Lazard Middle Market have been retained as advisors for separate sell-offs of the healthcare analytics and marketing & publishing services businesses, respectively.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Agency

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.